Padikara Chunnam for Urolithiasis

Phase II non randomized open clinical evaluation of Siddha medicine Padikara Chunnam for the management of Vatha Kalladaippu (UROLITHIASIS) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062444

Enrollment

Registered

2024-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: PADIKARA CHUNNAM: This Siddha herbal drug will begiven as 390mg to 650 mg , BD dose with neeraagaram, for 21 days for the management of Urolithiasis Intervention2: Padikara chunnam: Thi

Eligibility

Inclusion criteria

Inclusion criteria: LOWER ABDOMINAL PAIN FLANK PAIN BURNING MICTURITION STONE SIZE 4 TO 10 MM HAEMATURIA

Exclusion criteria

Exclusion criteria: Hydronephrosis, pregnancy,stag horn calculus, Calculi associated with serum creatinine level

Design outcomes

Primary

Measure	Time frame
Reduction in stone size and evaluation of stoneTimepoint: 21 days	—

Secondary

Measure	Time frame
Reduce clinical symptoms like Lower Abdominal pain,flank pain , Haematuria, burning micturitionTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr ANBU N

Government siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026